Subscribe to stay informed!
Malvern-based Fujirebio Diagnostics has received marketing authorization from the FDA for its diagnostic test for Alzheimer’s disease, writes John George for the Philadelphia…
Obamacare’s new-in-2013 medical device tax is killing the potential for new jobs at medical device developers like Malvern’s Fujirebio Diagnostics, according…
Before we send you to , pleasesubscribe to our daily newsletter.